Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;67(8):970-5.
doi: 10.1001/archneurol.2010.177.

Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease

Affiliations

Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease

Kenya Nishioka et al. Arch Neurol. 2010 Aug.

Abstract

Objective: To determine the association of the genes that encode alpha-, beta-, and gamma-synuclein (SNCA, SNCB, and SNCG, respectively) with diffuse Lewy body disease (DLBD).

Design: Case-control study. Subjects A total of 172 patients with DLBD consistent with a clinical diagnosis of Parkinson disease dementia/dementia with Lewy bodies and 350 clinically and 97 pathologically normal controls.

Interventions: Sequencing of SNCA, SNCB, and SNCG and genotyping of single-nucleotide polymorphisms performed on an Applied Biosystems capillary sequencer and a Sequenom MassArray pLEX platform, respectively. Associations were determined using chi(2) or Fisher exact tests.

Results: Initial sequencing studies of the coding regions of each gene in 89 patients with DLBD did not detect any pathogenic substitutions. Nevertheless, genotyping of known polymorphic variability in sequence-conserved regions detected several single-nucleotide polymorphisms in the SNCA and SNCG genes that were significantly associated with disease (P = .05 to <.001). Significant association was also observed for 3 single-nucleotide polymorphisms located in SNCB when comparing DLBD cases and pathologically confirmed normal controls (P = .03-.01); however, this association was not significant for the clinical controls alone or the combined clinical and pathological controls (P > .05). After correction for multiple testing, only 1 single-nucleotide polymorphism in SNCG (rs3750823) remained significant in all of the analyses (P = .05-.009).

Conclusion: These findings suggest that variants in all 3 members of the synuclein gene family, particularly SNCA and SNCG, affect the risk of developing DLBD and warrant further investigation in larger, pathologically defined data sets as well as clinically diagnosed Parkinson disease/dementia with Lewy bodies case-control series.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Linkage disequilibrium patterns for SNCA (A), SNCB (B), and SNCG (C). Values are given as r2. Numbered boxes represent exons.
Figure 2
Figure 2
Phylogenic and evolutionary analysis of the DNA sequences for SNCA, SNCB, and SNCG from Homo sapiens (Hom), Mus musculus (Mus), Gallus gallus (Gal), and Xenopus laevis (Xen) were performed using phylemon.

Similar articles

  • INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?
    Gámez-Valero A, Canet-Pons J, Urbizu A, Anillo A, Santos C, Ariza A, Beyer K. Gámez-Valero A, et al. J Alzheimers Dis. 2018;65(1):207-219. doi: 10.3233/JAD-180074. J Alzheimers Dis. 2018. PMID: 30040713
  • [Role of genetics in the etiology of synucleinopathies].
    Elcoroaristizabal Martín X, Gómez Busto F, González Fernández MC, de Pancorbo MM. Elcoroaristizabal Martín X, et al. Rev Esp Geriatr Gerontol. 2011 Oct;46 Suppl 1:3-11. doi: 10.1016/j.regg.2011.10.002. Rev Esp Geriatr Gerontol. 2011. PMID: 22152908 Review. Spanish.
  • Genetics of Synucleinopathies.
    Nussbaum RL. Nussbaum RL. Cold Spring Harb Perspect Med. 2018 Jun 1;8(6):a024109. doi: 10.1101/cshperspect.a024109. Cold Spring Harb Perspect Med. 2018. PMID: 28213435 Free PMC article. Review.
  • Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
    Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG, Kumaran R, Langston R, Bonet-Ponce L, Alcalay RN, Hassin-Baer S, Greenbaum L, Iwaki H, Leonard HL, Grenn FP, Ruskey JA, Sabir M, Ahmed S, Makarious MB, Pihlstrøm L, Toft M, van Hilten JJ, Marinus J, Schulte C, Brockmann K, Sharma M, Siitonen A, Majamaa K, Eerola-Rautio J, Tienari PJ; 23andMe Research Team; Pantelyat A, Hillis AE, Dawson TM, Rosenthal LS, Albert MS, Resnick SM, Ferrucci L, Morris CM, Pletnikova O, Troncoso J, Grosset D, Lesage S, Corvol JC, Brice A, Noyce AJ, Masliah E, Wood N, Hardy J, Shulman LM, Jankovic J, Shulman JM, Heutink P, Gasser T, Cannon P, Scholz SW, Morris H, Cookson MR, Nalls MA, Gan-Or Z, Singleton AB. Blauwendraat C, et al. Brain. 2020 Jan 1;143(1):234-248. doi: 10.1093/brain/awz350. Brain. 2020. PMID: 31755958 Free PMC article.
  • α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.
    Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF; SNCA Cognition Study Group; Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ. Guella I, et al. Ann Neurol. 2016 Jun;79(6):991-9. doi: 10.1002/ana.24664. Epub 2016 May 5. Ann Neurol. 2016. PMID: 27091628

Cited by

References

    1. Kosaka K. Diffuse Lewy body disease. Intern Med. 1998;37(1):6–10. - PubMed
    1. McKeith IG, Dickson DW, Lowe J, et al. Consortium on DLB Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65(12):1863–1872. - PubMed
    1. Fujishiro H, Ferman TJ, Boeve BF, et al. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol. 2008;67(7):649–656. - PMC - PubMed
    1. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology. 2001;57(8):1497–1499. - PubMed
    1. Dickson DW, Liu W, Hardy J, et al. Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol. 1999;155(4):1241–1251. - PMC - PubMed

Publication types